Completed
NA
INTERVENTIONAL
NCT00002302
The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZT
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
To determine the safety and efficacy of erythropoietin administered subcutaneously to AIDS patients with anemia secondary to their disease and/or concomitant zidovudine (AZT) therapy. Efficacy will be assessed by correction of anemia and decrease in transfusion requirements.
Interventions
Name:
Epoetin alfa
Type:
DRUG
Description:
Trial Information
NCT ID
NCT00002302
Status
Completed
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
Ortho Pharmaceuticals
Last Updated
December 15, 2025